Upgrade to SI Premium - Free Trial

Cardlytics (CDLX) Tops Q4 EPS by 37c

March 1, 2022 4:19 PM

Cardlytics (NASDAQ: CDLX) reported Q4 EPS of ($0.05), $0.37 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $90 million versus the consensus estimate of $76.58 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

Categories

Earnings

Next Articles